NYMXF
NYMOX PHARMACEUTICAL CORP
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 20-F/A | 9/29/2026 | View on SEC |
| 20-F/A | 9/16/2026 | View on SEC |
| 20-F | 9/14/2026 | View on SEC |
| 6-K | 8/31/2026 | View on SEC |
| 6-K | 8/7/2026 | View on SEC |
| 6-K | 6/3/2026 | View on SEC |
| 6-K | 3/27/2026 | View on SEC |
| 6-K | 11/7/2025 | View on SEC |
| 6-K | 10/22/2025 | View on SEC |
| 6-K | 10/22/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NYMXF |
| Company Name | NYMOX PHARMACEUTICAL CORP |
| CIK | 1018735 |
| Sector | In Vitro & In Vivo Diagnostic Substances |
| Industry | Accelerated filer |
| Exchange | OTC |
| SIC Code | 2835 |
| SIC Description | In Vitro & In Vivo Diagnostic Substances |
| Entity Type | other |
| Fiscal Year End | 1231 |
| Phone | 1-800-936-9669 |